{
    "paper_id": "d3c2e2839498c613ee95739dce7052109750362c",
    "metadata": {
        "title": "Long-Term Persistence of IgG Antibodies in SARS-CoV Infected Healthcare Workers 2 3",
        "authors": [
            {
                "first": "Xiaoqin",
                "middle": [],
                "last": "Guo",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Sun Yat-sen University",
                    "location": {
                        "postCode": "510080",
                        "settlement": "Guangzhou",
                        "country": "P. R. 7 China"
                    }
                },
                "email": ""
            },
            {
                "first": "Zhongmin",
                "middle": [],
                "last": "Guo",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Sun Yat-sen University",
                    "location": {
                        "postCode": "510080",
                        "country": "P. R. China"
                    }
                },
                "email": ""
            },
            {
                "first": "Chaohui",
                "middle": [],
                "last": "Duan",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Clinical Laboratory",
                    "institution": "Sun Yat-sen University",
                    "location": {
                        "postCode": "10 510080",
                        "settlement": "Guangzhou",
                        "country": "P. R. China"
                    }
                },
                "email": ""
            },
            {
                "first": "Zeliang",
                "middle": [],
                "last": "Chen",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Sun Yat-sen University",
                    "location": {
                        "postCode": "510080",
                        "settlement": "Guangzhou",
                        "country": "P. R. 7 China"
                    }
                },
                "email": ""
            },
            {
                "first": "Guoling",
                "middle": [],
                "last": "Wang",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Sun Yat-sen University",
                    "location": {
                        "postCode": "510080",
                        "settlement": "Guangzhou",
                        "country": "P. R. 7 China"
                    }
                },
                "email": ""
            },
            {
                "first": "Yi",
                "middle": [],
                "last": "Lu",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Boston University",
                    "location": {
                        "addrLine": "12",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Mengfeng",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Boston University",
                    "location": {
                        "addrLine": "12",
                        "country": "USA"
                    }
                },
                "email": ""
            },
            {
                "first": "Li",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jiahai",
                "middle": [],
                "last": "Lu",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Sun Yat-sen University",
                    "location": {
                        "postCode": "510080",
                        "settlement": "Guangzhou",
                        "country": "P. R. 7 China"
                    }
                },
                "email": "lujiahai@mail.sysu.edu.cnfor"
            },
            {
                "first": "Jiahai",
                "middle": [
                    "Lu"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "23 BACKGROUND 24 The ongoing worldwide outbreak of the 2019-nCoV is markedly similar to the severe acute 25 respiratory syndrome (SARS) outbreak 17 years ago. During the 2002-2003 SARS outbreak, 26 healthcare workers formed a special population of patients. Although virus-specific IgG play 27 important roles in virus neutralization and prevention against future infection, limited information is 28 available regarding the long term persistence of IgG after infection with SARS-like coronavirus.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "29",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "METHODS",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "A long-term prospective cohort study followed 34 SARS-CoV-infected healthcare workers from a 31 hospital with clustered infected cases during the 2002-2003 SARS outbreak in Guangzhou, China, 32 with a 13-year follow-up. Serum samples were collected annually from 2003-2015. Twenty 33 SARS-CoV-infected and 40 non-infected healthcare workers were enrolled in 2015, and their serum 34 samples were collected. All sera were tested for IgG antibodies with ELISA using whole virus and a 35 recombinant nucleocapsid protein of SARS-CoV, as a diagnostic antigen.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "36",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "RESULTS",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "Anti SARS-CoV IgG was found to persist for up to 12 years. IgG titers typically peaked in 2004,",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "declining rapidly from 2004-2006, and then continued to decline at a slower rate. IgG titers in 39 . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20021386 doi: medRxiv preprint SARS-CoV-infected healthcare workers remained at a significantly high level until 2015. Patients 40 treated with corticosteroids at the time of infection were found to have lower IgG titers than those 41 without. 42 CONCLUSIONS 43 IgG antibodies against SARS-CoV can persist for at least 12 years. The presence of SARS-CoV IgG 44 might provide protection against SARS-CoV and other betacoronavirus. This study provides valuable 45 information regarding humoral immune responses against SARS-CoV and the 2019-nCoV.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "46 47",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "(which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20021386 doi: medRxiv preprint concerns that SARS-CoV will re-emerge in the future; consequently, studies are underway to 69 determine the mechanisms through which SARS-CoV interacts with the host immune system, crosses 70 host barriers, and other related aspects.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "SARS-CoV was initially identified as having occurred through interspecies transmission from small 72 carnivores (e.g., palm civets and raccoon dogs) to humans in 2003. 10 In our current study, we conducted a 13-year follow-up study on a cohort of SARS-CoV-infected 87 healthcare workers for analyzing the presence and persistence of antibodies against SARS-CoV.",
            "cite_spans": [
                {
                    "start": 168,
                    "end": 170,
                    "text": "10",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "71"
        },
        {
            "text": ". CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "88"
        },
        {
            "text": "(which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20021386 doi: medRxiv preprint",
            "cite_spans": [],
            "ref_spans": [],
            "section": "88"
        },
        {
            "text": "The study site was a teaching hospital and the main center for treating clustered SARS cases in is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "90"
        },
        {
            "text": "(which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20021386 doi: medRxiv preprint were missing in the follow-up (Table S2) respectively, for failing to arrange a physical examination or due to resignation. In addition, serum 112 samples from another 20 subjects, from the 95 SARS cases, were collected in 2015 (Table S3) .",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 167,
                    "end": 177,
                    "text": "(Table S2)",
                    "ref_id": null
                },
                {
                    "start": 365,
                    "end": 375,
                    "text": "(Table S3)",
                    "ref_id": null
                }
            ],
            "section": "90"
        },
        {
            "text": "Another 40 non-SARS infected healthcare workers from the same hospital were enrolled and serum 114 samples were collected, as the control group, to verify the end result data of the 34 115 SARS-CoV-infected healthcare cohort in 2015 (Table S4 ). ",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 233,
                    "end": 242,
                    "text": "(Table S4",
                    "ref_id": null
                }
            ],
            "section": "113"
        },
        {
            "text": ". CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "126"
        },
        {
            "text": "The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20021386 doi: medRxiv preprint",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not peer-reviewed)"
        },
        {
            "text": "Boxplots and heatmaps were used to show the temporal trends and variations in the antibody levels.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "127"
        },
        {
            "text": "Non-linear exponential decay models were used to estimate the average decay rates of the antibody CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "128"
        },
        {
            "text": ". CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "168"
        },
        {
            "text": "The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20021386 doi: medRxiv preprint",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not peer-reviewed)"
        },
        {
            "text": "To analyze the general IgG distributions, subjects were divided into 2 groups: group 1 (n=46),",
            "cite_spans": [],
            "ref_spans": [],
            "section": "170"
        },
        {
            "text": "including SARS-CoV-infected healthcare workers enrolled in the original cohort (n=26) and 172 an additional group of SARS-CoV-infected healthcare workers who were enrolled in 2015 173 (n=20), and group 2 (n=40) of non-infected healthcare worker, selected as the control. The 174 IgG against whole virus was above the cutoff value, and the IgG titers were significantly 175 higher in group 1 than in group 2 (p < 0.001; Figure 3A) . A similar trend was observed for",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 419,
                    "end": 429,
                    "text": "Figure 3A)",
                    "ref_id": null
                }
            ],
            "section": "171"
        },
        {
            "text": "IgG against N199 titers, as group 1 had significantly higher IgG titers than group 2 (p=0.034; 177 Figure 3B ). Moreover, in group 1 the positive rate of IgG binding to whole virus and N199 178 was 58.70% and 28.26% with statiscical significance (p < 0.005), respectively.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 99,
                    "end": 108,
                    "text": "Figure 3B",
                    "ref_id": null
                }
            ],
            "section": "176"
        },
        {
            "text": "Kappa test was used to estimate the consistency between the methods for testing IgG. The (Table S5) .",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 89,
                    "end": 99,
                    "text": "(Table S5)",
                    "ref_id": null
                }
            ],
            "section": "179"
        },
        {
            "text": ". CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "187"
        },
        {
            "text": "The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20021386 doi: medRxiv preprint",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not peer-reviewed)"
        },
        {
            "text": "During the outbreak, some SARS-CoV-infected healthcare workers received corticosteroid 190 treatment, while others did not. The cohort was divided into two groups to assess the effect of antigen was used to detect its specific antibody, which has been demonstrated to be specific in 226 clinical diagnosis and SARS-CoV reservoir screening. 21 We therefore adopted the testing of 227 IgG against N199, combined with the titer analysis of IgG against the whole virus, to 228 comprehensively evaluate the SARS antibody duration.",
            "cite_spans": [
                {
                    "start": 340,
                    "end": 342,
                    "text": "21",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "189"
        },
        {
            "text": ". CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "229"
        },
        {
            "text": "The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20021386 doi: medRxiv preprint",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not peer-reviewed)"
        },
        {
            "text": "We found that the SARS-CoV-infected healthcare workers who were treated with 230 corticosteroids, such as prednisone and methylprednisolone, exhibited lower IgG titers during 231 the early stages of the disease than those who were not treated with corticosteroids (although 232 not significantly for IgG against N199). However, no differences were found between the two 233 groups after 2003, suggesting that corticosteroids may suppress the early production of 234 SARS-CoV IgG antibodies.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not peer-reviewed)"
        },
        {
            "text": "In our cohort, we found that two healthcare workers might have been misdiagnosed with 236 SARS, as the IgG antibodies against both the whole virus and N199 antigen was persistently 237 lower than the cutoff value, for these two patients. Notably, all the cases enrolled in this study is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "235"
        },
        {
            "text": "(which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20021386 doi: medRxiv preprint 2015.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "235"
        },
        {
            "text": "Collectively, based on our results, we can infer that the IgG against SARS-CoV can persist at CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "272"
        },
        {
            "text": "(which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20021386 doi: medRxiv preprint",
            "cite_spans": [],
            "ref_spans": [],
            "section": "272"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "The severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Peiris",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "Y"
                    ],
                    "last": "Yuen",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "D"
                    ],
                    "last": "Osterhaus",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Stohr",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "N Engl J 300 Med",
            "volume": "349",
            "issn": "",
            "pages": "2431--2472",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Identification of a novel coronavirus in patients with 302 severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Drosten",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gunther",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Preiser",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "N Engl J Med",
            "volume": "348",
            "issn": "",
            "pages": "1967--76",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Spatial pattern of severe acute respiratory syndrome in-out flow 304 in 2003 in Mainland China",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "BMC Infect Dis",
            "volume": "14",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Coronavirus respiratory illness in Saudi Arabia",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "N"
                    ],
                    "last": "Al-Ahdal",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Al-Qahtani",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Rubino",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "J Infect",
            "volume": "306",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Prevalence of IgG antibody to SARS-associated coronavirus in 308 animal traders",
            "authors": [],
            "year": 2003,
            "venue": "MMWR Morbidity and mortality weekly report",
            "volume": "309",
            "issn": "",
            "pages": "986--993",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Heroes of SARS: professional roles and ethics of health care workers",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "H"
                    ],
                    "last": "Hsin",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "R"
                    ],
                    "last": "Macer",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J 311 Infect",
            "volume": "49",
            "issn": "",
            "pages": "210--215",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Anti-SARS-CoV immunoglobulin G in healthcare workers",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "Q"
                    ],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "Y"
                    ],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "W"
                    ],
                    "last": "Wong",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "China's latest SARS outbreak has been contained",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "H"
                    ],
                    "last": "Organization",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "",
            "volume": "7",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Canadian officials watch SARS-like mystery bug",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Kondro",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Lancet",
            "volume": "362",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Isolation and characterization of viruses related to the SARS 318 coronavirus from animals in southern China",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Guan",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "J"
                    ],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "Q"
                    ],
                    "last": "He",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Science",
            "volume": "302",
            "issn": "",
            "pages": "276--284",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Isolation and characterization of a bat SARS-like coronavirus that 320 uses the ACE2 receptor",
            "authors": [
                {
                    "first": "X",
                    "middle": [
                        "Y"
                    ],
                    "last": "Ge",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "L"
                    ],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Nature",
            "volume": "503",
            "issn": "",
            "pages": "535--543",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Structure of SARS coronavirus spike receptor-binding 324 domain complexed with receptor",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Farzan",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Harrison",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Science",
            "volume": "309",
            "issn": "",
            "pages": "1864--1872",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Isolation of a novel 326 coronavirus from a man with pneumonia in Saudi Arabia",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Zaki",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Van Boheemen",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "Bestebroer",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "D"
                    ],
                    "last": "Osterhaus",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "Fouchier",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "N Engl J Med",
            "volume": "367",
            "issn": "",
            "pages": "1814--1834",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Human infection with MERS coronavirus after exposure 328 to infected camels, Saudi Arabia",
            "authors": [
                {
                    "first": "Z",
                    "middle": [
                        "A"
                    ],
                    "last": "Memish",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Cotten",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Meyer",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Emerg Infect Dis",
            "volume": "20",
            "issn": "",
            "pages": "1012--1017",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Longitudinal profiles of immunoglobulin G antibodies against severe 330 acute respiratory syndrome coronavirus components and neutralizing activities in recovered patients",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xie",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Two-year prospective study of the humoral immune response 333 of patients with severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Fontanet",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "H"
                    ],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "J Infect Dis",
            "volume": "193",
            "issn": "",
            "pages": "792--797",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "A three-year follow-up study on sera specific antibody in severe 335 acute respiratory syndrome cases after the onset of illness",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "Y"
                    ],
                    "last": "Xie",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Zeng",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Xia",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Zhonghua Liu Xing Bing Xue Za Zhi",
            "volume": "336",
            "issn": "",
            "pages": "343--348",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Disappearance of antibodies to 338 SARS-associated coronavirus after recovery",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "C"
                    ],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "H"
                    ],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Richardus",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "N Engl J Med",
            "volume": "357",
            "issn": "",
            "pages": "1162--1165",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "31, 2019, an outbreak of coronavirus causing infections in Wuhan, China, was officially 51 reported. The outbreak rapidly spread to several provinces of China and other countries. Currently, the 52 ongoing outbreak in China caused by a new coronavirus, named 2019-nCoV by WHO, is becoming a 53 global crisis. Notably, the 2019-nCoV is highly similar to the severe acute respiratory syndrome 54 coronavirus (SARS-CoV), which is characterized by high mortality and infectivity. Therefore,55information on SARS-CoV will be valuable for the prevention and control of the current outbreak.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "56 SARS was first confirmed in Guangdong, China in 2002-2003, and subsequently became a pandemic, 57 spreading rapidly to 31 countries and regions, causing panic and a global public health crisis. 1-3 In 58 total, 8,422 SARS cases were reported to the World Health Organization (WHO) with a case fatality 59 rate of 10.88% (916/8,422); of these total cases, 5,327 cases and 349 deaths were reported from 29 60 provinces of China. Guangdong was among the most affected provinces, with 1,511 reported cases, 61 22.90% (346/1,511) of which occurred in healthcare workers. 3-5 During emergency disease control, 62 frontline healthcare workers, including physicians, nurses, and other healthcare workers, who were 63 exposed to the virus while treating and caring for SARS patients in the early stages of the outbreaks, 64 were mainly affected. During the later stages of the outbreak, although precautions to prevent the 65 infection were enhanced, infection of healthcare workers still occurred. 6,7 No natural SARS-CoV 66 infections have been identified since the last confirmed case in May 2004. 8 The reasons why SARS 67 caused a transient epidemic and was experienced as an isolated event, remain unelucidated. 9 There are 68 .",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "79 respiratory syndrome coronavirus (MERS-CoV), emerged in the Middle East in 2012. MERS-CoV 80 has been shown to be transmissible from camels to humans, highlighting the ongoing threat posed by 81 SARS-CoV or other SARS-like viruses. 14,15 82 SARS-CoV IgG antibodies have neutralization activities and provide protection against infections.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Presence of IgG antibodies against virus and nucleocapsid protein represents protective immune 84 responses. While some previous studies reported longitudinal profiles of SARS IgG antibodies for up 85 to 5 years, 16-20 there has been a lack of knowledge on humoral immune responses for longer durations.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "Guangzhou, China. The hospital employed 4,797 staff, possessed 2,140 annual open 92 beds, and treated over 3.2 million patients annually. During the outbreak (from February to March, 93 2003), a total of 95 healthcare workers, out of all the staff in this hospital, were diagnosed with SARS 94 according to the diagnostic criteria promulgated by the Health Bureau of Guangdong (published on 95 February 3, 2003), and 34 of these cases were enrolled in this study. The majority of the participants 96 were aged between 20 and 30, in 2003, and 94.11% (32/34) of them were females (Table S1). The 97 enrollment criteria included clinical diagnosis of SARS-CoV infection in a healthcare worker treated 98 in the above mentioned hospital, the date of onset being prior to April 16, 2003, and an estimated 99 long-term follow-up of more than 9 years.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": "The sera used in this study is derived sample of the annual physical examination of the SARS-CoV 101 infected healthcare workers. Antibody surveillance is a part of the examination. The annual physical 102 examination has been reviewed and supported by the hospital ethics review committee. Written 103 consent was signed at the first examination.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "of 362 serum samples was collected. This included samples collected at the time of hospital 106 admission in 2003, from all study participants, and yearly sample collection, when the participants 107 attended their annual phyical examinations (April to June from 2004 through 2015).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF8": {
            "text": ": there was an interruption of sample collection in 2012 or 109 2013 due to an unexpected absence of the investigators in charge of sample collections; samples of 6 110 subjects were not collected in 2014 (Patient No. 29 -34) and 2015 (Patient No. 26 -28, 31-33) 111",
            "latex": null,
            "type": "figure"
        },
        "FIGREF9": {
            "text": "DETECTION AND QUANTIFICATION OF IgG ANTIBODIES 117 Serum IgG antibodies were detected with a SARS-CoV IgG antibody enzyme-linked immunosorbent 118 assay (ELISA) Kit (BGI-GBI Biotech Co. Ltd., Beijing, China), which used the whole SARS-CoV as 119 the detection antigen. Briefly, the serum samples were added at a 1:10 diluion and incubated in 120 pre-coated plates. After the processes of washing, reacting with HRP-labeled goat anti-human IgG, 121 color developing, and stopping the reaction, the absorbance was measured at 450 nm using a plate 122 reader. The IgG antibodies against nucleocapsid protein were detected with a recombinant SARS-CoV 123 N199 antigen assay developed in our laboratory as described previously 21 . Indirect ELISA was 124 performed to detect and quantify antibodies (at 1:10 dilution) against SARS-CoV N199 in the serum 125 samples, as previously described by Guo et al 21 .",
            "latex": null,
            "type": "figure"
        },
        "FIGREF10": {
            "text": "129 level. A non-parametric Mann Whitney U test was used to compare the IgG values of samples from 130 SARS-CoV-infected healthcare workers with those from the control in 2015. The test was also used to 131 compare the anti-SARS-CoV IgG titers from SARS-CoV-infected healthcare workers who were 132 treated with or without corticosteroids in 2003. We used the Kappa test to estimate the consistence of 133 the results of a positive rate for both methods in the samples of the SARS-CoV-infected healthcare 134 worker group from 2003 to 2005 and non-infected healthcare worker group in 2015. Missing values 135 were replaced with estimated values from exponential decay models. Additionally, we conducted a 136 comparison for the decay trend of the data with and without the missing value replacements.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF12": {
            "text": "PROFILES OF IgG AGAINST SARS-CoV FROM 2003 TO 2015 139 ELISA detection results showed that the IgG levels peaked in 2004, declined quickly from 2004 to 140 2006, and further decreased at a slower rate to a mean OD450nm value of 0.286 (against whole virus) 141 and 0.330 (against N199) in 2015 (Figure 1, A and B). IgG levels against SARS-CoV varied between 142 individuals, with the OD450nm range from 1.162 to 0.48 for IgG against whole virus, and 2.374 to 143 0.581 for IgG against N199. Notably, two healthcare workers, who were diagnosed as 144 SARS-CoV-infected patients, were negative for IgG against both the whole virus and N199, over the 145 .",
            "latex": null,
            "type": "figure"
        },
        "FIGREF14": {
            "text": "IgG levels against whole virus in 4 SARS infected healthcare workers increased notably after 148 2004, two of which also showed an increase in IgG antibodies against N199, while their levels in 149 other SARS infected healthcare workers decreased continuously during the following years (Figure 1, 150 C and D).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF15": {
            "text": "In the 13-year follow-up cohort, 80 out of 442 (18.10%) serum samples were lost. We used the 152 exponential regression of curve estimation method to estimate the missing values (Figure 1). Next, we 153 adopted the exponential decay models to define antibody decay, and the results indicated that the154 antibody titers exhibited an overall declining trend in IgG against both whole virus and N199 (Figure 155 2, A and B). A similar decay trend inf IgG titers was found, although the missing values were not 156 replaced in the model (Figures S1 and S2). Furthermore, the proportion of study participants with IgG 157 titer against whole virus (> cutoff value) was 81.25% (26/32) in 2003, peaked at 100.00% (32/32) in 158 2007, and decreased to 69.23% (18/26) in 2015 (Figure 2C). For IgG antibody against N199, the 159 initial positive (higher than the cutoff value) was 59.38% (19/32) in 2003, peaked at 87.50% (28/32) 160 in 2005, and finally decreased to 19.23% (5/26) in 2015 (Figure2D). The proportion of both the IgGs 161 exhibited a reduced trend, and the higher level (>2 cutoff value) declined annually until it reached 162 26.92 % (IgG against whole virus) and 0.00% (IgG against N199) in 2015 (Figure 2, C and D).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF16": {
            "text": "Two healthcare workers, patient No. 11 and No. 26, who had previously been diagnosed with164 SARS-CoV infection, were identified not to have detectable levels of IgG against N199 over the period (2003-2015). Anti-N199 IgG titers for patient No. 33 were also negative for all the 166 samples collected except the ones collected in 2005. The IgG titer against the whole virus in these 167 patients were weakly positive.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF17": {
            "text": "180 consistency test was mainly focused on the period from 2003-2005, as the IgG titers remained 181 stable during this period. Over this period, only 10 of the 102 cases showed inconsistent 182 results between the two detection methods, and the Kappa coefficient was 0.712, suggesting a 183 good general consistence between the results obtained through the whole virus and N199 184 ELISA methods. Similarly, in the control group, only 5 of the 40 cases displayed inconsistent 185 results, and the Kappa coefficient was -0.42, also indicating a general data consistency 186 between the two methods",
            "latex": null,
            "type": "figure"
        },
        "FIGREF18": {
            "text": "191 corticosteroid use on IgG titers in 2003. Of the 32 SARS-CoV-infected patients (with 2 cases 192 excluded as suspected to have been misdiagnosed), medical records were available for 27 193 patients, and the records showed that 17 of these patients were, and the rest were not, treated 194 with corticosteroids during the initial care for SARS in the 2002-2003 outbreak(Table S6). In195SARS patients with corticosteroids treatment and those not treated with corticosteroids, the 196 IgG against the whole virus was 0.35 \u00b1 0.24 and 0.58 \u00b1 0.29, respectively (p=0.03;Figure 1974A), and the IgG against N199 was 0.56 \u00b1 0.40 and 0.72 \u00b1 0.51, respectively. Although IgG 198 against N199 of patients not treated with corticosteroids were higher than those treated with 199 corticosteroids, the difference was not statistically significant (Figure 4B; p=0.17).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF19": {
            "text": "first confirmed in Guangdong, China in 2003, and subsequently became a 202 pandemic as it spread rapidly to other countries and regions. Cases from Guangdong 203 accounted for nearly 20% of reported cases and approximately 17% of reported healthcare 204 worker cases worldwide. Healthcare workers, in particular, were exposed to an extremely 205 high risk in combating SARS due to limited knowledge of the etiology and other natures of 206 SARS outbreak. Presently, 17 years after the last SARS outbreak, a new SARS-CoV-like 207 virus, 2019-nCoV, a new member of the betacoronavirus, is causing large scale outbreak in a large cluster of healthcare worker infections was officially reported on 211 January 20, 2020 at an early stage of this outbreak. Since information regarding this new 212 betacoronavirus outbreak remains largely unknown, evidence and knowledge from 213 SARS-CoV may provide important clues, aiding our responses to the outbreak.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF20": {
            "text": "IgG antibodies are proven to be important for virus neutralization and immunological 215 protection. As the first sampling of sera was performed during the early stage of SARS, it was 216 not possible to determine the maximum antibody titer, as this would be expected to occur 217 approximately 4 months after the onset of the outbreak. 19 Knowledge of the persistence and 218 level of antibodies against SARS-CoV, particularly neutralizing antibodies, is important for 219 evaluating the immune protection duration and vaccine efficacy. Neutralizing antibodies are 220 normally tested by viral neutralization tests; however, as manipulation involving live 221 SARS-CoV is prohibited in China in the interest of preventing laboratory-acquired SARS 222 infection and potential outbreaks, an alternative approach was employed to detect specific 223 IgG antibodies using SARS-CoV whole virus as capture antigens, which has been suggested 224 in previous studies to correlate with neutralizing activity 16 . Moreover, the SARS-CoV N199 225",
            "latex": null,
            "type": "figure"
        },
        "FIGREF21": {
            "text": "238 were admitted to the hospital between February and March, 2003, and that all the diagnoses 239 made before WHO's announcement that SARS-CoV was the causative agent of SARS on 240 April 16, 2003 1 , were based on the epidemiological features, clinical symptoms, and regular 241 laboratory blood tests, because serological and etiological diagnostic methods were not 242 available. Specifically, atypical pneumonia, as it was commonly known prior to adoption of 243 the SARS nomenclature, could also be caused by other pathogens. 22 Based on the results of 244 our current 13-year serological follow-up study, it is possible that the two healthcare workers 245 might have been misdiagnosed. Thus, it warrants further investigation to clarify whether these 246 two subjects were non-responders who did not develop anti-SARS-CoV antibodies at all or 247 simply represented misdiagnosed cases. In the latter scenario, the number of SARS cases in 248 the early stage of 2002-2003 SARS outbreak may need to be reassessed. Presently, for the 249 2019-nCoV outbreak, nucleic acid-based assay and particular real time PCR, are the",
            "latex": null,
            "type": "figure"
        },
        "FIGREF22": {
            "text": "During the SARS outbreak, the typical SARS patients mainly presented with antibodies 254 positive for SARS-CoV, fever, and symptoms of respiratory tract infections. Additionally, 255 there was a small group of asymptomatic SARS-CoV-nfected subjects, who only presented 256 with antibodies positive for SARS-CoV, but showed an absence of clinical symptoms. 23-25 . In 257 this study, we found that four subjects had an abnormal increase in the titers of SARS-CoV 258 antibodies during the follow-up. In contrast, the titers of SARS-CoV antibodies in most of the 259 other healthcare workers appeared to decrease slowly. It is unclear if these four healthcare 260 workers were reinfected with SARS-CoV or other coronaviruses with no signs or symptoms.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF23": {
            "text": "Thus, further investigation is needed to clarify whether these healthcare workers elicited IgG 262 response by SARS-CoV or other coronaviruses. In the former situation, the novel mechanism 263 of IgG generation without the clinical SARS symptoms needs to be elucidated.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF24": {
            "text": "IgG against SARS-CoV declined from 2003 to 2015 gradually, IgG levels in 265 SARS-CoV-infected healthcare workers were significantly higher than those in the 266 non-infected healthcare workers control group in 2015. The infected cases enrolled into the 267 study in 2015, exhibited detectable IgG against whole virus, and the positive rate was ~60%.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF25": {
            "text": "IgG against N199, the positive rate was ~30% in 2015. Moreover, results of the 269 exponential decay curve revealed that IgG antibodies against the whole virus were positive 270 throughout the 13-year follow-up, while IgG antibodies against N199 were negative only in 271 .",
            "latex": null,
            "type": "figure"
        },
        "FIGREF26": {
            "text": "273 least for 12 years. Presently, we are unaware whether the persistent IgG antibodies possess 274 virus neutralization activities and can provide complete protection against SARS-CoV 275 infection or cross protection against the new betacoronavirus, 2019-nCoV. From previous 276 studies, we predicted that the presence of IgG antibodies could at least provide a partial 277 protection against coronavirus infection. These data will be valuable for better understanding 278 the immune mechanisms and vaccine development strategies against SARS-CoV and 279 2019-nCoV, therefore being helpful for responses against the ongoing coronavirus outbreak.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF28": {
            "text": "collaborators participating in sample collection during the cohort study. This work 285 is supported by Guangdong Province Key Area R & D Plan Project (2018B020241002).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF29": {
            "text": "Lu designed the study, X. Guo, Z. Guo performed the ELISA tests, Z. Duan collected samples, Z.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF30": {
            "text": "Chen analyzed the data and revised the manuscript. G. Wang, Y. Lu and M. Li participated in",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Recently, studies indicate that SARS-CoV may have originated from bats. Bat coronavirus isolates have been shown to be able to recognize both human and bat ACE2 receptors. 11 Coronaviruses can exploit numerous cellular 75 receptors and potentially cause various illnesses such as respiratory and gastrointestinal diseases. 12Particularly, the spike protein is an important viral determinant of virus-receptor interaction, interspecies transmission, and host tropism, and its mutation can facilitate cross-species infection and 78 human-to-human transmission. 13 Another novel coronavirus similar to SARS-CoV, the middle-east",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "(which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20021386 doi: medRxiv preprint mainstream methods for etiological diagnosis. However, the sensitivity and specificity of 251 these assays need careful evaluation, because any false positive or negative results might be 252 harmful to the subjects.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": ". CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "339"
        },
        {
            "text": "The copyright holder for this preprint . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not peer-reviewed)"
        },
        {
            "text": ". CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "389"
        },
        {
            "text": "The red line is the cutoff value (0.40). P value of < 0.05 (two-tai) is considered to be statistically 400 significant (*).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "399"
        },
        {
            "text": ". CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.(which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20021386 doi: medRxiv preprint",
            "cite_spans": [],
            "ref_spans": [],
            "section": "402 403"
        }
    ]
}